VYNE Therapeutics Inc. — All Filings
608 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
4/A
424B2
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001104659-26-026439 | Mar 11, 2026 | — |
| 10-K | 10-K | 0001566044-26-000002 | Feb 27, 2026 | Dec 31, 2025 |
| 425 | 425 | 0001104659-26-008646 | Jan 30, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-008642 | Jan 30, 2026 | — |
| 4 | — | 0001727794-26-000002 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001867033-26-000002 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001727756-26-000002 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001727809-26-000002 | Jan 5, 2026 | Dec 31, 2025 |
| 425 | 425 | 0001104659-25-121829 | Dec 17, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-121828 | Dec 17, 2025 | — |
| 4 | — | 0001632295-25-000005 | Dec 15, 2025 | Dec 12, 2025 |
| 4 | — | 0001055404-25-000004 | Dec 15, 2025 | Dec 12, 2025 |
| 4 | — | 0001417397-25-000004 | Dec 15, 2025 | Dec 12, 2025 |
| 4 | — | 0001240499-25-000004 | Dec 15, 2025 | Dec 12, 2025 |
| 8-K | FORM 8-K | 0001104659-25-120637 | Dec 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112496 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001580642-25-007308 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-004954 | Nov 14, 2025 | — |
| ARS | ARS | 0001104659-25-110373 | Nov 12, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001104659-25-110346 | Nov 12, 2025 | Dec 12, 2025 |
| 10-Q | 10-Q | 0001566044-25-000010 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001566044-25-000007 | Nov 6, 2025 | — |
| 4 | — | 0001867033-25-000003 | Oct 2, 2025 | Sep 30, 2025 |
| 4 | — | 0001727756-25-000003 | Oct 2, 2025 | Sep 30, 2025 |
| 4 | — | 0001727809-25-000003 | Oct 2, 2025 | Sep 30, 2025 |
| 4 | — | 0001727794-25-000003 | Oct 2, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001104659-25-089531 | Sep 12, 2025 | Sep 11, 2025 |
| SCHEDULE 13G/A | — | 0001580642-25-005147 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-040366 | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0001172661-25-003435 | Aug 14, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-078135 | Aug 14, 2025 | Aug 11, 2025 |
| 8-K | FORM 8-K | 0001104659-25-071953 | Jul 30, 2025 | — |
| 4 | — | 0001415889-25-019059 | Jul 2, 2025 | Jun 30, 2025 |
| 4 | — | 0001415889-25-019058 | Jul 2, 2025 | Jun 30, 2025 |
| 4 | — | 0001415889-25-019057 | Jul 2, 2025 | Jun 30, 2025 |
| 4 | — | 0001415889-25-019056 | Jul 2, 2025 | Jun 30, 2025 |
| 4 | — | 0001415889-25-015383 | Jun 3, 2025 | Jun 2, 2025 |
| 4 | — | 0001415889-25-015382 | Jun 3, 2025 | Jun 2, 2025 |
| SCHEDULE 13G/A | — | 0000929638-25-001952 | May 19, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-049627 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002196 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-023740 | May 8, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001628280-25-023478 | May 8, 2025 | — |
| 4 | — | 0001415889-25-009633 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | — | 0001415889-25-009632 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | — | 0001415889-25-009631 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | — | 0001415889-25-009629 | Apr 2, 2025 | Mar 31, 2025 |
| 10-K | 10-K | 0001628280-25-010908 | Mar 6, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001628280-25-010777 | Mar 6, 2025 | — |
| 4 | — | 0001415889-25-001927 | Jan 23, 2025 | Jan 21, 2025 |